- Report
- November 2023
- 100 Pages
Global
From €5730EUR$5,950USD£4,928GBP
- Report
- May 2024
- 353 Pages
Global
From €5393EUR$5,600USD£4,638GBP
- Report
- February 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- February 2024
- 150 Pages
Global
From €7656EUR$7,950USD£6,584GBP
- Report
- November 2023
- 150 Pages
Global
From €4285EUR$4,450USD£3,686GBP
- Report
- December 2023
- 150 Pages
Middle East, Africa
From €2393EUR$2,485USD£2,058GBP
€3419EUR$3,550USD£2,940GBP
- Report
- December 2020
- 66 Pages
Global
From €819EUR$850USD£704GBP
- Report
- February 2022
- 197 Pages
Global
From €3067EUR$3,185USD£2,638GBP
€4382EUR$4,550USD£3,768GBP
- Report
- August 2022
- 141 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- August 2022
- 117 Pages
Global
From €4334EUR$4,500USD£3,727GBP
- Report
- May 2023
- 186 Pages
Global
From €3067EUR$3,185USD£2,638GBP
€4382EUR$4,550USD£3,768GBP
- Report
- May 2023
- 186 Pages
Global
From €3067EUR$3,185USD£2,638GBP
€4382EUR$4,550USD£3,768GBP
- Report
- February 2021
- 35 Pages
Global
€1269EUR$1,318USD£1,092GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €482EUR$500USD£414GBP
- Report
- January 2019
- 35 Pages
Global
From €963EUR$1,000USD£828GBP
- Report
- April 2023
- 147 Pages
Global
From €5777EUR$5,999USD£4,968GBP
Dysport is a brand of botulinum toxin type A, a prescription medication used to treat certain neurological conditions. It is used to treat muscle spasms, excessive sweating, and wrinkles. Dysport is a competitor to Botox, another brand of botulinum toxin type A. Dysport is approved for use in more than 75 countries, including the United States, Canada, and the European Union.
Dysport is a part of the Central Nervous System Drugs market, which includes medications used to treat neurological conditions. These drugs are used to treat a variety of conditions, including Parkinson's disease, multiple sclerosis, and epilepsy.
Companies in the Dysport market include Ipsen, Merz Pharmaceuticals, and Galderma. Ipsen is the manufacturer of Dysport, while Merz Pharmaceuticals and Galderma are the distributors. Show Less Read more